Statin use vs. average non-HDL cholesterol levels, 2019
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins area type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases inpeople at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.
Select countries and regions
Sort by
Name
All countries and regions
Interactive visualization requires JavaScript
Related research and data
Charts
- Average HDL cholesterol levelsage-standardized
- Average non-HDL cholesterol levelsage-standardized
- Cardiac magnetic resonance imaging (MRI) units per million people
- Cardiac surgeons per million people
- Cardiologists per million people
- Cardiovascular death rate: crude versus age-standardizedWHO Mortality Database, age-standardized, reported
- Catheterization labs per million people
- Computed tomography (CT) imaging units per million people
- Coronary angiographies and diagnostic cardiac catheterizations per million people
- Coronary stents per million people
- Death rate from cardiomyopathy, myocarditis and endocarditisWHO Global Health Estimates, age-standardized, estimated
- Death rate from cardiovascular diseasesWHO Global Health Estimates, age-standardized, estimated
- Death rate from cardiovascular diseasesWHO Mortality Database, crude, reported
- Death rate from cardiovascular diseasesIHME, crude
- Death rate from cardiovascular diseasesWHO Mortality Database, age-standardized, reported
- Death rate from cardiovascular diseasesWHO Global Health Estimates, crude, estimated
- Death rate from cardiovascular diseases by age groupIHME, crude
- Death rate from cardiovascular diseases by age groupWHO Mortality Database, crude, reported
- Death rate from cardiovascular diseases by risk factorIHME, age-standardized
- Death rate from cardiovascular diseases by sexWHO Mortality Database, age-standardized, reported
- Death rate from cardiovascular diseases by sexWHO Mortality Database, age-standardized, reported, scatterplot
- Death rate from cardiovascular diseases in 15- to 49-year oldsIHME
- Death rate from cardiovascular diseases vs. GDP per capita
- Death rate from hypertensionIHME, age-standardized
- Death rate from hypertensionIHME, crude
- Death rate from hypertensive heart diseasesWHO
- Death rate from ischaemic heart diseaseWHO
- Death rate from rheumatic heart diseasesWHO
- Death rate from strokeWHO, age-standardized
- Death rate from strokeIHME, age-standardized
- Death rate from strokeIHME, crude
- Death rate from stroke by age groupIHME
- Death rates from different causesWHO Mortality Database, age-standardized
- Death rates from different causes in France over the 20th century
- Death rates from different causes in the United States over the 20th century
- Gamma camera or nuclear medicine units per million people
- Hospitals with cath labs per million people
- Hospitals with dedicated heart failure centers per million people
- Hospitals with dedicated stroke units per million people
- Implantable cardioverter defibrillator (ICD) per million people
- Incidence rate of cardiovascular diseasesIHME, age-standardized
- Magnetic resonance imaging (MRI) units per million people
- Number of deaths from cardiovascular diseasesWHO Global Health Estimates, estimated
- Number of deaths from cardiovascular diseasesIHME
- Number of deaths from cardiovascular diseases by ageIHME
- Number of deaths from cardiovascular diseases by regionWHO Global Health Estimates, estimated
- Number of deaths from cardiovascular diseases by risk factorIHME, age-standardized
- Number of deaths from cardiovascular diseases by typeWHO Global Health Estimates, estimated
- Number of deaths from hypertensionIHME
- Number of deaths from strokeWHO
- Number of deaths from strokeIHME
- Number of deaths from stroke by ageIHME
- Pacemaker implantations per million people
- Positron emission tomography (PET) imaging units per million people
- Prevalence rate of cardiovascular diseasesIHME, age-standardized
- Prevalence rate of diabetes in adultsWHO Global Health Observatory, age-standardized, estimated
- Prevalence rate of hypertension in adults aged 30-79
- Prevalence rate of hypertension in men aged 30-79
- Prevalence rate of hypertension in women aged 30-79
- Prevalence rate of obesity in adultsAge-standardized
- Share of adults who smoke
- Share of deaths from cardiovascular diseases
- Share of deaths from cardiovascular diseases by sexWHO Mortality Database
- Share of deaths from major causesWHO Mortality Database
- Share of deaths from underlying causes
- Share of percutaneous coronary interventions (PCI) performed by transradial access
- Statin accessibility in the public health sector
- Statin use
- Statin use by people with cardiovascular diseases to prevent complications
- Statin use to prevent the development of cardiovascular diseases
- Statin use vs death rate from cardiovascular diseases